文献速递甲状腺疾病

基于多组学分析的中国人群甲状腺乳头状癌细胞DNA甲基化表观遗传特征

Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population.
PubMed 文献 · Thyroid · 2025-05-30

研究收集中国患者甲状腺癌组织40例与良性甲状腺结节组织31例,进行全基因组DNA甲基化分析,并结合基因表达谱和H3K27ac修饰分析。研究发现中国甲状腺乳头状癌患者存在独特的甲状腺激素合成相关低甲基化模式,并鉴定出7个具有高灵敏度和特异性的功能差异性甲基化区域用于诊断,DHRS3被突出为关键基因。结论需在更大独立队列中进一步验证。

要点

  • 中国PTC患者存在独特的甲状腺激素合成相关低甲基化模式。
  • 鉴定出7个功能差异性甲基化区域对甲状腺癌诊断具有高灵敏度和特异性。
  • DHRS3被突出为PTC发病关键基因及预测患者结局的潜在生物标志物。

核心结论

  • 研究提供中国PTC患者基于多组学、功能导向的DNA甲基化全景图。
  • 鉴定出7个功能差异性甲基化区域对中国患者甲状腺癌诊断具有高灵敏度和特异性。
  • DHRS3被突出为PTC发病关键因子,并显示作为预测患者结局的生物标志物的前景。

研究设计与样本

  • 收集中国患者甲状腺癌组织40例和良性甲状腺结节组织31例进行全基因组DNA甲基化分析。
  • 同时研究基因表达谱和H3K27ac修饰以理解表观遗传改变对基因表达的影响。
  • 采用全基因组甲基化谱分析和机器学习方法区分PTC与对照样本。

主要发现

  • 全基因组DNA甲基化图谱揭示中国PTC组织存在显著甲基化组改变。
  • 将数据与癌症基因组图谱甲状腺癌甲基化谱整合,鉴定出中国PTC患者特有的甲状腺激素合成相关低甲基化模式。
  • RNA测序和H3K27ac修饰分析及功能实验显示,PTC患者中失调基因对甲状腺癌的增殖、迁移和侵袭至关重要。

局限性

  • 需要在更大独立队列中进一步验证以确认其诊断价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Thyroid cancer is the most common endocrine malignancy, with papillary thyroid cancer (PTC) accounting for ∼80% of all cases. DNA methylation alterations and gene expression changes in cancer, offer valuable insights into tumor biology and serve as potential clinical biomarkers. However, the functional implications of DNA methylation changes in PTC patients, particularly based on multiomics analysis in the Chinese population, remain insufficiently explored. This study aims to investigate the epigenetic signatures of thyroid cancer and identify the DNA methylation biomarkers for diagnosing PTC in Chinese patients. Methods: Thyroid cancer tissues (n = 40) and benign thyroid nodule tissues (n = 31) were collected from Chinese patients for global DNA methylation analysis. Gene expression profiles and H3K27ac modifications were also investigated to understand the impacts of epigenetic changes on gene expression. Genome-wide methylation profiling and machine learning methods were employed to differentiate PTC from control samples. Results: Genome-wide DNA methylation maps revealed significant methylome changes in Chinese PTC tissues. By integrating our data with The Cancer Genome Atlas thyroid cancer methylation profiles, we identified unique hypomethylation patterns associated with thyroid hormone synthesis specifically in Chinese PTC patients. RNA sequencing and H3K27ac modification analysis, along with functional assays, showed that the dysregulated genes in PTC patients are critical for the proliferation, migration, and invasion of thyroid cancer. Conclusions: Our study provides a comprehensive view of the multi-omics-based, function-guided DNA methylation landscape for Chinese PTC patients. We identified seven functional differentially methylated regions with high sensitivity and specificity for diagnosing thyroid cancer in Chinese patients. Additionally, DHRS3 is highlighted as a key player in PTC pathogenesis and shows promise as a valuable biomarker for predicting patient outcomes. This research advances our understanding of DNA methylation in thyroid cancer and underscores the importance of developing population-specific diagnostic tools to improve patient outcomes. However, further validation in larger, independent cohorts is needed to confirm their diagnostic value.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ruan X, Yang F, Li M, et al. Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population. Thyroid. 2025. PMID: 40441683. doi:10.1089/thy.2024.0611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。